Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chevalier

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Science Advances|March 5, 2025
Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantationMathieu F Chevalier, Vincent Allain, Julien Gras, et al.
Blood Advances|June 21, 2022
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphomaAlexis Cuffel, Vincent Allain, Lionel Faivre, et al.
European Urology|March 10, 2017
Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial CancerMathieu F Chevalier, Perrine Bohner, Claire Pieraerts, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2020
Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 CountsRoseline Affi, Delphine Gabillard, Catherine Dunyach-Remy, et al.
Iscience|February 9, 2026
BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4<sup>+</sup> Th1 responsesPaul Rollin, Benjamin Pluskwa, Emilie Artru, et al.
The Journal of Clinical Investigation|June 27, 2017
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrenceMathieu F Chevalier, Sara Trabanelli, Julien Racle, et al.
Journal for Immunotherapy of Cancer|December 15, 2023
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potentialLaurent Derré, Ilaria Lucca, Valérie Cesson, et al.
Journal of Virology|November 5, 2010
HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell functionMathieu F Chevalier, Boris Jülg, Augustine Pyo, et al.
Frontiers in Microbiology|May 7, 2026
Environmental resistome of culturable gram-negative bacilli from the Yaque del Norte River: baseline genomic evidence for one health surveillanceMaría F Chevalier-Alba, Dionis I Hoepelman, Larianna Pineda-Cabrera, et al.
Scientific Reports|July 26, 2024
Role of mucosal-associated invariant T cells dynamics in pathogenesis of Sjögren syndromeJeanne Chauffier, Henri Berger de Gallardo, Mathieu F Chevalier, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Science Advances|March 5, 2025
Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantationMathieu F Chevalier, Vincent Allain, Julien Gras, et al.
Blood Advances|June 21, 2022
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphomaAlexis Cuffel, Vincent Allain, Lionel Faivre, et al.
European Urology|March 10, 2017
Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial CancerMathieu F Chevalier, Perrine Bohner, Claire Pieraerts, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2020
Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 CountsRoseline Affi, Delphine Gabillard, Catherine Dunyach-Remy, et al.
Iscience|February 9, 2026
BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4<sup>+</sup> Th1 responsesPaul Rollin, Benjamin Pluskwa, Emilie Artru, et al.
The Journal of Clinical Investigation|June 27, 2017
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrenceMathieu F Chevalier, Sara Trabanelli, Julien Racle, et al.
Journal for Immunotherapy of Cancer|December 15, 2023
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potentialLaurent Derré, Ilaria Lucca, Valérie Cesson, et al.
Journal of Virology|November 5, 2010
HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell functionMathieu F Chevalier, Boris Jülg, Augustine Pyo, et al.
Frontiers in Microbiology|May 7, 2026
Environmental resistome of culturable gram-negative bacilli from the Yaque del Norte River: baseline genomic evidence for one health surveillanceMaría F Chevalier-Alba, Dionis I Hoepelman, Larianna Pineda-Cabrera, et al.
Scientific Reports|July 26, 2024
Role of mucosal-associated invariant T cells dynamics in pathogenesis of Sjögren syndromeJeanne Chauffier, Henri Berger de Gallardo, Mathieu F Chevalier, et al.
Pageof 12